The decline in the reported number of new transmissions of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections across European Union (EU) and European Economic Area (EEA) countries has continued.
This joint guidance by the ECDC and EMCDDA aims to strengthen the evidence base for developing national strategies for preventing and controlling infections and infectious diseases among people who inject drugs.
This document is an update of the joint guidance that was published in 2011 by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
Did you know that there can be harmful bacteria in your food if it is not handled properly? Luckily, there are steps you can take to protect your health and your family's. Watch the video to learn more.
This issue of the CDTR covers the period 11 – 17 December 2022 and includes updates on COVID-19, diphtheria, measles, streptococcal infection, invasive meningococcal disease, poliomyelitis, influenza, mass gathering monitoring, and Ebola virus disease.
The purpose of this review was to identify and synthesise the existing evidence on effectiveness of interventions targeting people who inject drugs at two stages of the care cascade: linkage to care and adherence to treatment of HIV, hepatitis B/C and TB.